Top

Published in:

01-01-2014 | Original Paper

The Effectiveness of Lifestyle Interventions to Reduce Cardiovascular Risk in Patients with Severe Mental Disorders: Meta-Analysis of Intervention Studies

Authors: Maria Isabel Fernández-San-Martín, Luis Miguel Martín-López, Roser Masa-Font, Noemí Olona-Tabueña, Yuani Roman, Jaume Martin-Royo, Silvia Oller-Canet, Susana González-Tejón, Luisa San-Emeterio, Albert Barroso-Garcia, Lidia Viñas-Cabrera, Gemma Flores-Mateo

Published in: Community Mental Health Journal | Issue 1/2014

Abstract

Patients with severe mental illness have higher prevalences of cardiovascular risk factors (CRF). The objective is to determine whether interventions to modify lifestyles in these patients reduce anthropometric and analytical parameters related to CRF in comparison to routine clinical practice. Systematic review of controlled clinical trials with lifestyle intervention in Medline, Cochrane Library, Embase, PsycINFO and CINALH. Change in body mass index, waist circumference, cholesterol, triglycerides and blood sugar. Meta-analyses were performed using random effects models to estimate the weighted mean difference. Heterogeneity was determined using i² statistical and subgroups analyses. 26 studies were selected. Lifestyle interventions decrease anthropometric and analytical parameters at 3 months follow up. At 6 and 12 months, the differences between the intervention and control groups were maintained, although with less precision. More studies with larger samples and long-term follow-up are needed.

Álvarez-Jiménez, M., González-Blanch, C., Vázquez-Barquero, J. L., Pérez-Iglesias, R., Martínez-García, O., Pérez-Pardal, T., et al. (2006). Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial. Journal of Clinical Psychiatry, 67, 1253–1260.PubMedCrossRef

Alvarez-Jiménez, M., Hetrick, S. E., González-Blanch, C., Gleeson, J. F., & McGorry, P. D. (2008). Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials. British Journal of Psychiatry, 193(2), 101–107.PubMedCrossRef

Ball, M. P., Coons, V. B., & Buchanan, R. W. (2001). A program for treating olanzapine-related weight gain. Psychiatric Services (Washington, D. C.), 52(7), 967–969.CrossRef

Beebe, L. H., Tian, L., Morris, N., Goodwin, A., Allen, S. S., & Kuldau, J. (2005). Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues in Mental Health Nursing, 26(6), 661–676.PubMedCrossRef

Blouin, M., Binet, M., Bouchard, R. H., Roy, M. A., Després, J. P., & Alméras, N. (2009). Improvement of metabolic risk profile under second-generation antipsychotics: A pilot intervention study. Canadian Journal of Psychiatry, 54(4), 275–279.

Brar, J. S., Ganguli, R., Pandina, G., Turkoz, I., Berry, S., & Mahmoud, R. (2005). Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry, 66(2), 205–212.PubMedCrossRef

Centorrino, F., Wurtman, J. J., Duca, K. A., Fellman, V. H., Fogarty, K. V., Berry, J. M., et al. (2006). Weight loss in overweight patients maintained on atypical antipsychotic agents. International Journal of Obesity (London), 30(6), 1011–1016.CrossRef

Colton, C. W., & Manderscheid, R. W. (2006). Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease, 3(2), A42.PubMedCentralPubMed

De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I., & Möller, H. J. (2009). Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry, 24(6), 412–424.PubMedCrossRef

Evans, S., Newton, R., & Higgins, S. (2005). Nutritional intervention to prevent weight gain in patients commenced on olanzapine: A randomized controlled trial. Australian and New Zealand Journal of Psychiatry, 39(6), 479–486.PubMed

Faulkner, G., Cohn, T., & Remington, G. (2007). Interventions to reduce weight gain in schizophrenia. Cochrane Database Systematic Review, 24(1), CD005148.

Forsberg, K. A., Björkman, T., Sandman, P. O., & Sandlund, M. (2008). Physical health—a cluster randomized controlled lifestyle intervention among persons with a psychiatric disability and their staff. Nordic Journal of Psychiatry, 62(6), 486–495.PubMedCrossRef

Generalitat de Catalunya. (2003). Programa d’atenció Especifica als Trastorns Mentals Severs. Barcelona: Generalitat de Catalunya, Departament de Sanitat i Seguretat Social.

Goff, C., Cather, C., Evins, A. E., Henderson, D. C., Freudenreich, O., Copeland, P. M., et al. (2005). Medical morbidity and mortality in schizophrenia: Guidelines for psychiatrists. Journal of Clinical Psychiatry, 66(2), 183–194.PubMedCrossRef

Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., et al. (2005). American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735–2752.PubMedCrossRef

Higgins, J. P. T., & Green, S. (Eds.) (2011). Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org.

Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539–1558.PubMedCrossRef

Iglesias-Garcia, C., Toimil-Iglesias, A., & Alonso-Villa, M. J. (2010). Pilot study of the efficacy of an educational programme to reduce weight, on overweight and obese patients with chronic stable schizophrenia. Journal of Psychiatric and Mental Health Nursing, 17, 849–851.PubMedCrossRef

Jean-Baptiste, M., Tek, C., Liskov, E., Chakunta, U. R., Nicholls, S., Hassan, A. Q., et al. (2007). A pilot study of a weight management program with food provision in schizophrenia. Schizophrenia Research, 96(1–3), 198–205.PubMedCrossRef

Kwon, J. S., Choi, J. S., Bahk, W. M., Kim, C. Y., Kim, C. H., Shin, Y. C., et al. (2006). Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. Journal of Clinical Psychiatry, 67, 547–553.PubMedCrossRef

Littrell, K. H., Hilligoss, N. M., Kirshner, C. D., Petty, R. G., & Johnson, C. G. (2003). The effects of an educational intervention on antipsychotic-induced weight gain. Journal of Nursing Scholarship, 35(3), 237–241.PubMedCrossRef

Marrugat, J., Solanas, P., D’Agostino, R., Sullivan, L., Ordovas, J., Cordón, F., et al. (2003). Coronary risk estimation in Spain using a calibrated Framingham function. Revista Espanola de Cardiologia, 56(3), 253–261.PubMed

Marzolini, S., Jensen, B., & Melville, P. (2009). Feasibility and effects of a group-based resistance and aerobic exercise program for individuals with severe schizophrenia: A multidisciplinary approach. Mental Health and Physical Activity, 2, 29–36.CrossRef

May, H. J., Gazda, G. M., Powell, M., & Hauser, G. (1985). Life skill training: Psychoeducational training as mental health treatment. Journal of Clinical Psychology, 41(3), 359–367.PubMedCrossRef

McCreadie, R. G., Kelly, C., Connolly, M., Williams, S., Baxter, G., Lean, M., et al. (2005). Dietary improvement in people with schizophrenia: Randomised controlled trial. British Journal of Psychiatry, 187, 346–351.PubMedCrossRef

McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., et al. (2005). Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research, 80(1), 19–32.PubMedCrossRef

McKibbin, C. L., Golshan, S., Griver, K., Kitchen, K., & Wykes, T. L. (2010). A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: A 6-month follow-up analysis. Schizophrenia Research, 121(1–3), 203–206.PubMedCrossRef

McKibbin, C. L., Patterson, T. L., Norman, G., Patrick, K., Jin, H., Roesch, S., et al. (2006). A lifestyle intervention for older schizophrenia patients with diabetes mellitus: A randomized controlled trial. Schizophrenia Research, 86(1–3), 36–44.PubMedCrossRef

Melamed, Y., Stein-Reisner, O., Gelkopf, M., Levi, G., Sivan, T., Ilievici, G., et al. (2008). Multi-modal weight control intervention for people with persistent mental disorders. Psychiatric Rehabilitation Journal, 31(3), 194–200.PubMedCrossRef

Menza, M., Vreeland, B., Minsky, S., Gara, M., Radler, D. R., & Sakowitz, M. (2004). Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. Journal of Clinical Psychiatry, 65(4), 471–477.PubMedCrossRef

Perälä, J., Suvisaari, J., Saarni, S. I., Kuoppasalmi, K., Isometsä, E., Pirkola, S., et al. (2007). Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry, 64, 19–28.PubMedCrossRef

Porsdal, V., Beal, C., Kleivenes, O. K., Martinsen, E. W., Lindström, E., Nilsson, H., et al. (2010). The Scandinavian solutions for wellness study—a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders. BMC Psychiatry, 10, 42.PubMedCentralPubMedCrossRef

Poulin, M. J., Chaput, J. P., Simard, V., Vincent, P., Bernier, J., Gauthier, Y., et al. (2007). Management of antipsychotic-induced weight gain: Prospective naturalistic study of the effectiveness of a supervised exercise programme. Australian and New Zealand Journal of Psychiatry, 41(12), 980–989.PubMedCrossRef

Scocco, P., Longo, R., & Caon, F. (2006). Weight change in treatment with olanzapine and a psychoeducational approach. Eating Behaviors, 7(2), 115–124.PubMedCrossRef

SEMERGEN Doc. Factores de Riesgo Cardiovascular. (2005). Available from http://www.semergen.es/semergen/microsites/semergendoc/factores_cardiov/doc_complet.pdf.

Skrinar, G. S., Huxley, N. A., Hutchinson, D. S., Menninger, E., & Glew, P. (2005). The role of a fitness intervention on people with serious psychiatric disabilities. Psychiatric Rehabilitation Journal, 29(2), 122–127.PubMedCrossRef

Van Citters, A. D., Pratt, S. I., Jue, K., Williams, G., Miller, P. T., Xie, H., et al. (2010). A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness. Community Mental Health Journal, 46, 540–552.PubMedCentralPubMedCrossRef

Veit, T., & Barnas, C. (2009). Diet blues: Methodological problems in comparing non-pharmacological weight management programs for patients with schizophrenia. International Journal of Psychiatry in Clinical Practice, 13(3), 173–183.CrossRef

Vreeland, B., Minsky, S., Menza, M., Rigassio Radler, D., Roemheld-Hamm, B., & Stern, R. (2003). A program for managing weight gain associated with atypical antipsychotics. Psychiatric Services (Washington, D. C.), 54(8), 1155–1157.CrossRef

Weber, M., & Wyne, K. (2006). A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophrenia Research, 83(1), 95–101.PubMedCrossRef

Wu, M. K., Wang, C. K., Bai, Y. M., Huang, C. Y., & Lee, S. D. (2007). Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatric Services (Washington, D. C.), 58(4), 544–550.CrossRef

Wu, R. R., Zhao, J. P., Jin, H., Shao, P., Fang, M. S., Guo, X. F., et al. (2008). Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA, 299(2), 185–193.PubMedCrossRef

Title: The Effectiveness of Lifestyle Interventions to Reduce Cardiovascular Risk in Patients with Severe Mental Disorders: Meta-Analysis of Intervention Studies
Authors: Maria Isabel Fernández-San-Martín
Luis Miguel Martín-López
Roser Masa-Font
Noemí Olona-Tabueña
Yuani Roman
Jaume Martin-Royo
Silvia Oller-Canet
Susana González-Tejón
Luisa San-Emeterio
Albert Barroso-Garcia
Lidia Viñas-Cabrera
Gemma Flores-Mateo
Publication date: 01-01-2014
Publisher: Springer US
Published in: Community Mental Health Journal / Issue 1/2014
Print ISSN: 0010-3853
Electronic ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-013-9614-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The Effectiveness of Lifestyle Interventions to Reduce Cardiovascular Risk in Patients with Severe Mental Disorders: Meta-Analysis of Intervention Studies

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

The Connections Place: A Job Preparedness Program for Individuals with Borderline Personality Disorder

Effectiveness of the Chronic Disease Self-Management Program for Persons with a Serious Mental Illness: A Translation Study

Dialectical Behavior Therapy Training to Reduce Clinical Burnout in a Public Behavioral Health System

Psychiatry Residents’ Perception of Public/Community Psychiatry Fellowship Training

Reliability and Practicality of Measuring Waist Circumference to Monitor Cardiovascular Risk Among Community Mental Health Center Patients

“It’s Good for Me”: Physical Activity in Older Adults with Schizophrenia